Resident blog - Elise Lawrence
from The mTOR You Know Hosted by The mTOR You Know
On this resident blog, PGY2 SOT Elise Lawrence joins us from the University of Colorado Hospital to discuss a review of 3-year follow up data on outcomes after conversion from monthly to every 2-month belatacept maintenance therapy in low immunologic risk kidney transplant recipients, followed by a brief refresher on considerations for toxoplasmosis prophylaxis after solid organ transplant and what options to consider when patients can not utilize sulfamethoxazole-trimethoprim.
Embed this episode
No transcript yet.